[DEFA14A] NAYA Biosciences, Inc. Additional Proxy Soliciting Materials
NAYA Biosciences, Inc. has submitted a Schedule 14A – Definitive Additional Materials (Form DEFA14A) with the U.S. Securities and Exchange Commission. The filing indicates that the company, listed in the document under the legal name INVO Fertility, Inc., is providing supplemental proxy solicitation materials rather than a full definitive proxy statement. According to the cover page, the materials are filed by the registrant and no filing fee is required for this submission. No financial data, transaction details, or voting proposals are included in the excerpt provided.
NAYA Biosciences, Inc. ha presentato una Schedule 14A – Materiali Aggiuntivi Definitivi (Modulo DEFA14A) presso la U.S. Securities and Exchange Commission. Il documento indica che la società, elencata con il nome legale INVO Fertility, Inc., sta fornendo materiali supplementari per la sollecitazione di deleghe, anziché una dichiarazione definitiva completa. Secondo la pagina di copertina, i materiali sono presentati dal registrante e non è prevista alcuna tassa di deposito per questa sottomissione. Nell'estratto fornito non sono inclusi dati finanziari, dettagli di transazioni o proposte di voto.
NAYA Biosciences, Inc. ha presentado un Schedule 14A – Materiales Adicionales Definitivos (Formulario DEFA14A) ante la Comisión de Bolsa y Valores de EE.UU. El documento indica que la empresa, listada bajo el nombre legal INVO Fertility, Inc., está proporcionando materiales suplementarios para la solicitud de poder, en lugar de una declaración definitiva completa. Según la página de portada, los materiales son presentados por el registrante y no se requiere tarifa de presentación para esta entrega. No se incluyen datos financieros, detalles de transacciones ni propuestas de votación en el extracto proporcionado.
NAYA Biosciences, Inc.는 미국 증권거래위원회(SEC)에 Schedule 14A – 최종 추가 자료(Form DEFA14A)를 제출했습니다. 문서에는 회사가 법적 명칭인 INVO Fertility, Inc.로 등재되어 있으며, 전체 최종 위임장 성명서가 아닌 보충 위임장 요청 자료를 제공하고 있음을 나타냅니다. 표지 페이지에 따르면, 이 자료들은 등록자가 제출한 것이며 제출 수수료는 필요하지 않습니다. 제공된 발췌문에는 재무 데이터, 거래 세부사항 또는 투표 제안이 포함되어 있지 않습니다.
NAYA Biosciences, Inc. a déposé un Schedule 14A – Documents Complémentaires Définitifs (Formulaire DEFA14A) auprès de la Securities and Exchange Commission des États-Unis. Le dépôt indique que la société, mentionnée sous le nom légal INVO Fertility, Inc., fournit des documents supplémentaires pour la sollicitation de procurations plutôt qu’une déclaration définitive complète. Selon la page de couverture, les documents sont déposés par le déclarant et aucun frais de dépôt n’est requis pour cette soumission. Aucun détail financier, transactionnel ou proposition de vote n’est inclus dans l’extrait fourni.
NAYA Biosciences, Inc. hat bei der US-Börsenaufsichtsbehörde (SEC) eine Schedule 14A – Definitive Additional Materials (Formular DEFA14A) eingereicht. Die Einreichung zeigt, dass das Unternehmen, im Dokument unter dem rechtlichen Namen INVO Fertility, Inc. aufgeführt, ergänzende Proxy-Materialien bereitstellt und keine vollständige endgültige Proxy-Erklärung. Laut Titelseite wurden die Materialien vom Registranten eingereicht und für diese Einreichung ist keine Gebühr erforderlich. Im bereitgestellten Auszug sind keine Finanzdaten, Transaktionsdetails oder Abstimmungsvorschläge enthalten.
- None.
- None.
Insights
TL;DR: Routine DEFA14A filing; provides supplemental proxy info, no fee, no material impact.
This is a standard Definitive Additional Proxy Material filing (DEFA14A). Such filings typically supply shareholders with clarifying or additional information ahead of a meeting but seldom introduce new strategic actions. The absence of financial tables, proposals, or transaction disclosures implies that the content is purely administrative. Because no fee is due and no new items are flagged, the filing is unlikely to influence valuation or voting outcomes. Investors should await further proxy documentation for any actionable details.
NAYA Biosciences, Inc. ha presentato una Schedule 14A – Materiali Aggiuntivi Definitivi (Modulo DEFA14A) presso la U.S. Securities and Exchange Commission. Il documento indica che la società, elencata con il nome legale INVO Fertility, Inc., sta fornendo materiali supplementari per la sollecitazione di deleghe, anziché una dichiarazione definitiva completa. Secondo la pagina di copertina, i materiali sono presentati dal registrante e non è prevista alcuna tassa di deposito per questa sottomissione. Nell'estratto fornito non sono inclusi dati finanziari, dettagli di transazioni o proposte di voto.
NAYA Biosciences, Inc. ha presentado un Schedule 14A – Materiales Adicionales Definitivos (Formulario DEFA14A) ante la Comisión de Bolsa y Valores de EE.UU. El documento indica que la empresa, listada bajo el nombre legal INVO Fertility, Inc., está proporcionando materiales suplementarios para la solicitud de poder, en lugar de una declaración definitiva completa. Según la página de portada, los materiales son presentados por el registrante y no se requiere tarifa de presentación para esta entrega. No se incluyen datos financieros, detalles de transacciones ni propuestas de votación en el extracto proporcionado.
NAYA Biosciences, Inc.는 미국 증권거래위원회(SEC)에 Schedule 14A – 최종 추가 자료(Form DEFA14A)를 제출했습니다. 문서에는 회사가 법적 명칭인 INVO Fertility, Inc.로 등재되어 있으며, 전체 최종 위임장 성명서가 아닌 보충 위임장 요청 자료를 제공하고 있음을 나타냅니다. 표지 페이지에 따르면, 이 자료들은 등록자가 제출한 것이며 제출 수수료는 필요하지 않습니다. 제공된 발췌문에는 재무 데이터, 거래 세부사항 또는 투표 제안이 포함되어 있지 않습니다.
NAYA Biosciences, Inc. a déposé un Schedule 14A – Documents Complémentaires Définitifs (Formulaire DEFA14A) auprès de la Securities and Exchange Commission des États-Unis. Le dépôt indique que la société, mentionnée sous le nom légal INVO Fertility, Inc., fournit des documents supplémentaires pour la sollicitation de procurations plutôt qu’une déclaration définitive complète. Selon la page de couverture, les documents sont déposés par le déclarant et aucun frais de dépôt n’est requis pour cette soumission. Aucun détail financier, transactionnel ou proposition de vote n’est inclus dans l’extrait fourni.
NAYA Biosciences, Inc. hat bei der US-Börsenaufsichtsbehörde (SEC) eine Schedule 14A – Definitive Additional Materials (Formular DEFA14A) eingereicht. Die Einreichung zeigt, dass das Unternehmen, im Dokument unter dem rechtlichen Namen INVO Fertility, Inc. aufgeführt, ergänzende Proxy-Materialien bereitstellt und keine vollständige endgültige Proxy-Erklärung. Laut Titelseite wurden die Materialien vom Registranten eingereicht und für diese Einreichung ist keine Gebühr erforderlich. Im bereitgestellten Auszug sind keine Finanzdaten, Transaktionsdetails oder Abstimmungsvorschläge enthalten.
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 14A
Proxy Statement Pursuant to Section 14(a) of the
Securities Exchange Act of 1934
(Amendment No. )
| Filed by the Registrant ☒ | Filed by a Party other than the Registrant ☐ |
Check the appropriate box:
| ☐ | Preliminary Proxy Statement |
| ☐ | Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) |
| ☐ | Definitive Proxy Statement |
| ☒ | Definitive Additional Materials |
| ☐ | Soliciting Material Pursuant to §240.14a-12 |
INVO FERTILITY, INC.
(Name of Registrant as Specified in Its Charter)
(Name of Person(s) Filing Proxy Statement, if Other Than the Registrant)
Payment of Filing Fee (Check the appropriate box):
| ☒ | No fee required. |
| ☐ | Fee paid previously with preliminary materials. |
| ☐ | Fee computed on table in exhibit required by Item 2(b) per Exchange Act Rules 14a-6(i)(1) and 0-11. |
FAQ
What type of SEC filing did NAYA Biosciences (NAYA) submit?
Does the DEFA14A filing by NAYA Biosciences require a fee?
Who is listed as the registrant in the filing?
Are there any financial statements or earnings data included in this filing?
